Illumina HiSeq(NGS) System Market by 2017 - PowerPoint PPT Presentation

About This Presentation
Title:

Illumina HiSeq(NGS) System Market by 2017

Description:

[350 Pages Report] Next Generation Sequencing (NGS) Market categories the global market by Platforms (MiSeq, Illumina HiSeq, 454 Roche, Life Technologies Ion Proton/PGM, by Bioinformatics (RNA-Seq, ChIP-Seq), (SBS, SMRT & Pyrosequencing,), (Diagnostics, Personalized Medicine) & by Geography. – PowerPoint PPT presentation

Number of Views:548

less

Transcript and Presenter's Notes

Title: Illumina HiSeq(NGS) System Market by 2017


1
MarketsandMarkets Presents
Illumina HiSeq(NGS) System Market by 2017

http//www.marketsandmarkets.com/Market-Reports/ne
xt-generation-sequencing-ngs-technologies-market-5
46.html
2
The "Next Generation Sequencing (NGS) Market
Platforms (Illumina HiSeq, MiSeq, Life
Technologies Ion Proton/PGM, 454 Roche),
Bioinformatics (RNA-Seq, ChIP-Seq),
(Pyrosequencing, SBS, SMRT), (Diagnostics,
Personalized Medicine) Global Forecast to
2017"analyzes and studies the major market
drivers, restraints, and opportunities in North
America, Europe, Asia and Rest of World. Browse
87 market data tables with 25 figures spread
through 350 pages and in-depth TOC on this
report http//www.marketsandmarkets.com/Market-Rep
orts/next-generation-sequencing-ngs-technologies-m
arket-546.html Early buyers will receive 10
customization on this report.

3
This report studies the global NGS market over
the forecast period of 2012-2017. The global NGS
market was valued at 1.3 billion in 2012 and is
poised to reach 2.7 billion by 2017 at a CAGR of
16.3. The growth of the overall NGS market is
driven by continuous innovations and developments
in the market aimed at higher throughput,
increased accuracy, and affordable costs. The
opportunities for the growth of this market
include developments in pre-sequencing, cloud
computing, and NGS bioinformatics solutions.
However, factors such as high reliability on
grants and funding from the government and
decrease in capital expenditure from academic
institutions are hindering the growth of the
market. In addition, the interpretation of big
data generated by sequencers and the subsequent
storage and management of analyzed data is still
a challenge. Owing to the complexity of NGS
technologies and data, standardization of the
overall NGS workflow is still an unmet need.
4
This research report categorizes and analyzes the
global NGS market on the basis of steps in the
NGS workflow, NGS technologies, and NGS
applications. All these markets are further
divided into segments and sub-segments, to
provide exhaustive value analysis for the years
2010, 2011, 2012, and forecast to 2017. Based on
the NGS workflow, NGS pre-sequencing, sequencing
and data analysis form the overall NGS market.
Under pre-sequencing, the solutions for sample
preparation are covered. The sequencing market
covers platforms, reagents and services from key
players like Illumina (U.S.), Life Technologies
(U.S.), 454 Roche (U.S.), and Pacific Biosciences
(U.S.). The market for sequencing platforms has
been very dynamic. Some revolutionary platforms
like GA IIx (Illumina) and SOLiD Series (Life
Technologies) will take a setback and newer
platforms like MiSeq and Ion Torrent Proton will
gain market dominance. The NGS data analysis
market includes the market by product (software
and services) and by applications such as whole
genome sequencing, targeted re-sequencing, de
novo sequencing, RNA-Seq, ChIP-Seq and
Methyl-Seq. Some of the major applications of NGS
include diagnostics, drug discovery, biomarker
discovery, personalized medicine, and agriculture
and animals research. Each market is
comprehensively analyzed at a granular level by
geography (North America, Europe, Asia, and Rest
of the World) to provide in-depth information on
the global scenario.
5
North America accounted for the largest market
share of the NGS market, followed by Europe, in
2012. However, Asia presents significant
opportunities for investors as the developed
markets get saturated. The NGS platforms market
is a consolidated one and was dominated by
Illumina in 2012, which accounted for the largest
market share of more than 50. Other companies
with commercial platforms include Life
Technologies (U.S.), 454 Roche (U.S.), and
Pacific Biosciences (U.S.). The NGS
bioinformatics/data analysis market is highly
fragmented with key players like CLC bio
(Denmark), Biomatters (New Zealand), Partek
(U.S.), Genomatix (Germany), Knome (U.S.) and
DNASTAR (U.S.) dominating this market space.
6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/ne
xt-generation-sequencing-ngs-technologies-market-5
46.html
7
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Bloghttp//twitter.com/market
smarkets
http//www.linkedin.com/company/marketsandmarkets
Write a Comment
User Comments (0)
About PowerShow.com